Run#,Date Run,Description,Raw Data,Pipeline Output in S3 bucket rd-output
CG001Qv40Run01,2018-06-22,Annealing temp (60-64) optimization on Jenna TOne and BioRad C1000,180622_M02558_0234_000000000-BW2P5,
CG001Qv40Run02,2018-06-28,Annealing temp (58-62) optimization on Jenna TOne and BioRad C1001,180628_M02558_0235_000000000-BVKD2,
CG001Qv40Run03,2018-07-06,"FAILED (Gromit lost power) Annealing temp (58-62) optimization on Jenna TOne and BioRad C1000, primer swaps and doubling conc",,
CG001Qv40Run03,2018-07-10,"Repeat failed run on Gromit. Annealing temp (58-62) optimization on Jenna TOne and BioRad C1000, primer swaps and doubling conc",180710_M02558_0236_000000000-BW2N9,
CG001Qv40Run04,2018-07-19,"4th optimization with 20 FFPE samples and Horizon's OncoSpan (new hotspot reference standard), on Jenna TOne at 60C annealing, 25 cycles, 3C/s ramp,",180719_M03829_0149_000000000-BWLJW,180719_M03829_0149_000000000-BWLJW_version3
CG001Qv40Run5,2018-07-25,21 POLE DNA samples,180725_M02558_0238_000000000-BWLJK,180725_M02558_0238_000000000-BWLJK_version2
CG001Qv40Run6,2018-07-27,"9 POLE DNA samples, 12 Manitoba lung FFPEs (matched with 3 plasma samples in Run7 from batch-1, and 9 of 10 plasma samples from batch-2)",180727_M03829_0150_000000000-BWL6L,180727_M03829_0150_000000000-BWL6L_version2
CG001Qv40Run7,2018-08-01,Manitoba plasma and matched FFPE samples (batch-2),180731_M02558_0239_000000000-BYB56,180731_M02558_0239_000000000-BYB56_version2
CG001Qv40Run8,2018-08-04,"Manitoba plasma with different extraction methods, 3 commercial BioChain FFPE samples with known hotspots,",180803_M03829_0151_000000000-BY8YR,180803_M03829_0151_000000000-BY8YR_version2
CG001Qv40Run9,2018-08-04,DNA Mixtures,180803_M02558_0240_000000000-BWL83,180803_M02558_0240_000000000-BWL83_version2
CG001Qv40Run10,2018-08-09,DNA Mixtures,180808_M03829_0152_000000000-BWL8C,180808_M03829_0152_000000000-BWL8C_version2
CG001Qv40Run11,2018-08-11,DNA Mixtures,180810_M03829_0153_000000000-BM8YJ,180810_M03829_0153_000000000-BM8YJ_version2
CG001Qv40Run12,2018-08-15,DNA Mixtures,180814_M03829_0154_000000000-BYB63,180814_M03829_0154_000000000-BYB63_version2
CG001Qv40Run13,2018-08-16,"DNA Mixtures, Horizon Multiplex I cfDNA Reference Standards Set (5, 1, 0.1, WT) in Synthetic Plasma,",180815_M02558_0241_000000000-BWLKJ,180815_M02558_0241_000000000-BWLKJ_version2
CG001Qv40Run14,2018-08-18,"DNA Mixtures of Seraseq ctDNA 1% and WT, Seraseq ctDNA in synthetic plasma 1% and WT, GyneBank CG02631 trio, Qiagen Multiplex PCR mastermix lot-to-lot",180817_M03829_0155_000000000-BWLK6,180817_M03829_0155_000000000-BWLK6_version2
CG001Qv40Run15,2018-08-25,DNA Mixtures,180824_M03829_0156_000000000-C2PN4,180824_M03829_0156_000000000-C2PN4_version2
CG001Qv40Run16,2018-08-25,DNA Mixtures,180824_M02558_0243_000000000-C2J9D,180824_M02558_0243_000000000-C2J9D_version3
CG001Qv40Run17,2018-09-10,"Commercial OncoSpan sample dilutions with Tru-Q background. Seven commercially sourced (4 HemaCare, 3 AMSbio) plasma samples.",180910_M03829_0159_000000000-C2P4D,180910_M03829_0159_000000000-C2P4D_version4
CG001Qv40Run18,2018-09-06,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords; Repeat of failed run CG001Qv34Run78",180907_M02558_0244_000000000-C2JFB,180907_M02558_0244_000000000-C2JFB_version2
CG001Qv40Run19,2018-09-11,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180911_M02558_0245_000000000-C2J9N,180911_M02558_0245_000000000-C2J9N_version2
CG001Qv40Run20,2018-09-17,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords. NOTE: Fastq file of CG02643_DNA-10566 is 2G",180917_M03829_0160_000000000-C2J8C,180917_M03829_0160_000000000-C2J8C_version2 (see FIMP-191)
CG001Qv40Run21,2018-09-18,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180918_M02558_0246_000000000-C2J89,180918_M02558_0246_000000000-C2J89_version2
CG001Qv40Run22,2018-09-20,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180920_M03829_0161_000000000-C39CP,180920_M03829_0161_000000000-C39CP_version2
CG001Qv40Run23,2018-09-20,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180920_M02558_0247_000000000-C39YB,180920_M02558_0247_000000000-C39YB_version2
CG001Qv40Run24,2018-09-27,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180927_M02558_0251_000000000-C3CC6,180927_M02558_0251_000000000-C3CC6_version2
CG001Qv40Run25,2018-09-21,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords RUN FAILED (bad NaOH reagent)",180921_M02558_0248_000000000-C3BB4,
CG001Qv40Run26,2018-09-26,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180926_M02558_0250_000000000-C39DN,180926_M02558_0250_000000000-C39DN_version2
CG001Qv40Run27,2018-09-25,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",180925_M03829_0164_000000000-C39YD,180925_M03829_0164_000000000-C39YD_version2
CG001Qv40Run25(CG001Qv40Run25 rerun),2018-09-24,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords; Repeat of failed run",180924_M03829_0163_000000000-C39DC,180924_M03829_0163_000000000-C39DC_version2
CG001Qv40Run28,2018-09-27,"Group of 20 PolE samples, not previously sequenced without codewords",180927_M03829_0165_000000000-C39WW,180927_M03829_0165_000000000-C39WW_version2
CG001Qv40Run29,2018-10-01,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",181001_M02558_0252_000000000-C5695,181001_M02558_0252_000000000-C5695_version2
CG001Qv40Run30,2018-10-01,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",181001_M03829_0166_000000000-C4WMD,181001_M03829_0166_000000000-C4WMD_version2
CG001Qv40Run31,2018-10-18,"DNA Mixtures of Seraseq ctDNA 1% and WT, GyneBank CG02737-CG02739 trio",181018_M03829_0168_000000000-C4YCP,181018_M03829_0168_000000000-C4YCP_version2
CG001Qv40Run32,2018-10-05,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",181004_M02558_0253_000000000-C54G8,181004_M02558_0253_000000000-C54G8_version2
CG001Qv40Run33,2018-10-10,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords",181009_M03829_0167_000000000-C569D,181009_M03829_0167_000000000-C569D_version2
CG001Qv40Run34,2018-10-15,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched, not previously sequenced without codewords; Repeat of CG001Qv40Run20. Fastq file of sample CG02643_DNA-10566 is still large (1G)",181015_M02558_0255_000000000-C5699,
CG001Qv40Run35,2018-10-28,Manitoba matched FFPE and plasma; lot-to-lot validation of IDT-mixed v4 primer pools; lot-to-lot of QIAGEN Multiplex PCR kit,181030_M03829_0169_000000000-C52FR,181030_M03829_0169_000000000-C52FR_version2
CG001Qv40Run36,,NEVER RUN,,
CG001Qv40Run37,2018-11-02,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched",181102_M03829_0170_000000000-C572W,181102_M03829_0170_000000000-C572W_version2
CG001Qv40Run38,2018-11-05,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched",181105_M03829_0171_000000000-C5GGP,181105_M03829_0171_000000000-C5GGP_version2
CG001Qv40Run39,2018-11-05,"Group of 7 GyneBank samples with FFPE, plasma and buffy coat matched",181105_M02558_0258_000000000-C5NKK,181105_M02558_0258_000000000-C5NKK_version2
CG001Qv40Run40,2018-11-07,"Tissue for Research (Spectrum health) samples: 3 FFPE/Plasma duos, 5 FFPE/Buffy coat/Plasma trios",181107_M02558_0259_000000000-C5GP2,181107_M02558_0259_000000000-C5GP2_version2
CG001Qv40Run41,2018-11-07,FAILED RUN. 5 Tissue for Research (Spectrum health) FFPE/Buffy coat/Plasma trios; 1 gynebank trio; 1 twofold dilution of QMRS in TruQ0; 1 replicate of CG00368 for VAF discrepancy assessment,181107_M03829_0172_000000000-C5GDJ,
CG001Qv40Run41,2018-11-09,FAILED RUN. Resequenced. 5 Tissue for Research (Spectrum health) FFPE/Buffy coat/Plasma trios; 1 gynebank trio; 1 twofold dilution of QMRS in TruQ0; 1 replicate of CG00368 for VAF discrepancy assessment,181109_M02558_0260_000000000-C5NKM,
CG001Qv40Run42,2018-11-14,"QC run. Samples 1-12 amplified on Jena thermalcycler, 13-24 amplified on Biorad thermalcycler. Samples 1-3 and 13-15 standard controls. Samples 4,16 are twofold dilutions of QMRS in TruQ0. Samples 5-6 and 17-18 are new QMRS and NF libraries amplified from Run41 PCR product. Samples 7-12 and 19-24 are the first four Tissue for Research (Spectrum health) trios from Run41 (new libraries amplified from Run41 PCR product). New run42 PCR amplifications using new IDT generated primer tube aliquots (all previous runs from in-house mixed primer pools generated from IDT plates). Libraries were run on Agilent DNA-1000 and look better than Run41 in terms of intensity and peak shape.",181114_M02558_0261_000000000-C5GDT,181114_M02558_0261_000000000-C5GDT_version2
CG001Qv40Run43,2018-11-19,Find It validation run 1,181120_M02558_0263_000000000-C5GPG,181120_M02558_0263_000000000-C5GPG_version2
CG001Qv40Run44,2018-11-21,Find It validation run 2,181121_M03829_0175_000000000-C5GF5,181121_M03829_0175_000000000-C5GF5_version2
CG001Qv40Run45,2018-11-16,Find It validation run 3,181116_M02558_0262_000000000-C5GFY,181116_M02558_0262_000000000-C5GFY_version2
CG001Qv40Run46,2018-11-16,Find It validation run 4 (SECRET),181116_M03829_0174_000000000-C5GP8,181116_M03829_0174_000000000-C5GP8_version5
CG001Qv40Run47,2018-11-21,"Horizon cfDNA series DNA mass titration, 4 to 66 ng, 5/1/0.5/0.1 % VAFs, variable sequencing depth (on subsequent runs),",181121_M02558_0264_000000000-C5GGT,181121_M02558_0264_000000000-C5GGT_version3
CG001Qv40Run48,2018-11-22,Find It validation run 3 with v2 Nextera adapters group A-1. Libraries from Run 45 PCR product.,181122_M02558_0265_000000000-C5GH4,181122_M02558_0265_000000000-C5GH4_version2
CG001Qv40Run49,2018-11-22,Find It validation run 4 (SECRET) with v2 Nextera adapters group A-2. Libraries from Run 46 PCR product.,181122_M03829_0176_000000000-C5GP7,181122_M03829_0176_000000000-C5GP7_version3
CG001Qv40Run50,2018-11-23,Find It validation run 2 with v2 Nextera adapters group D-2. Libraries from Run 44 PCR product.,181123_M03829_0177_000000000-C5GD2,181123_M03829_0177_000000000-C5GD2_version2
CG001Qv40Run51,2018-11-24,Find It validation run 1 with v2 Nextera adapters group D-1. Libraries from Run 43 PCR product.,181124_M02558_0266_000000000-C5GCL,181124_M02558_0266_000000000-C5GCL_version2
CG001Qv40Run52,2018-11-27,Repeat of CG001Qv40Run10,181127_M03829_0178_000000000-C5GFT,181127_M03829_0178_000000000-C5GFT_version2
CG001Qv40Run53,2018-11-29,Follow It validation run 1,/181204_M02558_0271_000000000-C6MJC,181129_M02558_0268_000000000-C5GP3_version2
CG001Qv40Run54,2018-11-28,Follow It validation run 2,181128_M03829_0179_000000000-C5GCR,181128_M03829_0179_000000000-C5GCR_version2
CG001Qv40Run55,2018-11-28,"Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-8 for variable sequencing depth",181128_M02558_0267_000000000-C5GNB,181128_M02558_0267_000000000-C5GNB_version3
CG001Qv40Run56,2018-11-30,"Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-4 and 47-9 to 47-12 for variable sequencing depth",181130_M03829_0180_000000000-C6MPY,181130_M03829_0180_000000000-C6MPY_version3
CG001Qv40Run57,2018-12-03,"Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-4 and 47-13 to 47-16 for variable sequencing depth",181203_M02558_0269_000000000-C5GG5,181203_M02558_0269_000000000-C5GG5_version3
CG001Qv40Run58,2018-12-03,"Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-4 and 47-17 to 47-20 for variable sequencing depth",181203_M03829_0181_000000000-C6M8R,181203_M03829_0181_000000000-C6M8R_version3
CG001Qv40Run59,2018-12-04,"FAILED RUN. Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-4 and 47-21 to 47-24 for variable sequencing depth. Clustering failed, rerun as Run-60",,
CG001Qv40Run60,2018-12-04,"Horizon cfDNA series DNA mass titration, rerun of 47-1 to 47-4 and 47-21 to 47-24 for variable sequencing depth",181204_M02558_0271_000000000-C6MJC,181204_M02558_0271_000000000-C6MJC_version3
CG001Qv40Run61,2019-01-10,Group of 10 JMctDNA samples with frozen tissue and buffy coat matched (Batch 1); Lot-to-lot validation of QMRS,190110_M02558_0273_000000000-C6M84,190110_M02558_0273_000000000-C6M84_version2
CG001Qv40Run62,2019-01-14,Phusion HiFi enzyme optimization; FIND IT workflow optimization,190114_M03829_0185_000000000-C6MRP,190114_M03829_0185_000000000-C6MRP_version2
CG001Qv40Run63,2019-01-18,Hand mixing versus machine mixing of primers; only primer pool A is changed.,190118_M03829_0186_000000000-C6M56,190118_M03829_0186_000000000-C6M56_version3
CG001Qv40Run63_1,2019-01-18,Hand mixing versus machine mixing of primers; only primer pool A is changed.,190118_M03829_0186_000000000-C6M56_1,
CG001Qv40Run64 (6 mers),2019-01-24,10-mer versus 6-mer; only pool A is changed.,190124_M02558_0275_000000000-C6LTH_6mers,190124_M02558_0275_000000000-C6LTH_6mers
CG001Qv40Run64 (10mers),2019-01-24,10-mer versus 6-mer; only pool A is changed.,190124_M02558_0275_000000000-C6LTH_10mers,190124_M02558_0275_000000000-C6LTH_10mers
CG001Qv40Run65,2019-01-23,FAILED RUN (large amplicons went off the end of the gel) E-gel size-selected 4nM library of CG001Qv40Run54,190123_M03829_0187_000000000-C6LKY,190123_M03829_0187_000000000-C6LKY_version2
CG001Qv40Run66,2019-01-29,Group of 10 JMctDNA samples with pre-op and post-op plasma matched (Batch 1); Seraseq Lung & Brain CNV Mix +12 copies,190129_M03829_0188_000000000-C6M8H,190129_M03829_0188_000000000-C6M8H_version2
CG001Qv40Run67,2019-02-06,21 Exactis plasma samples,190206_M03829_0189_000000000-C6M83,190206_M03829_0189_000000000-C6M83_version2
CG001Qv40Run68,2019-02-11,9 Exactis plasma and 12 Manitoba plasma samples,190211_M02558_0278_000000000-C6M8P,190211_M02558_0278_000000000-C6M8P_version2
CG001Qv40Run69,2019-02-13,FIND/FOLLOW IT workflow optimization: 15 ul into LibCon instead of 5 ul; overall decreased DNA input into assay (3.3 & 1.1 ng),190213_M02558_0279_000000000-C944T,190213_M02558_0279_000000000-C944T_version2
CG001Qv40Run70,2019-02-12,"Group of 10 JMctDNA samples with FFPE, frozen tissue, and buffy coat matched (Batch 2); 1 twofold dilution of QMRS in TruQ0",190212_M03829_0191_000000000-C944P,190212_M03829_0191_000000000-C944P_version2
CG001Qv40Run71,2019-02-19,Group of 10 JMctDNA samples with pre-op and post-op plasma matched (Batch 2); 1 Manitoba plasma sample run on e-gel demo instrument,190219_M02558_0280_000000000-C94GY,190219_M02558_0280_000000000-C94GY_version2
CG001Qv40Run72,2019-02-19,"Group of 10 JMctDNA samples with frozen tissue, and buffy coat matched (Batch 3); 1 Manitoba plasma sample run on e-gel demo instrument",190219_M03829_0194_000000000-C8TV7,190219_M03829_0194_000000000-C8TV7_version2
CG001Qv40Run73,2019-03-06,Group of 10 JMctDNA samples with pre-op and post-op plasma matched (Batch 3),190306_M02558_0286_000000000-C93NN,190306_M02558_0286_000000000-C93NN_version2
CG001Qv40Run74,2019-02-25,"Sonic troubleshooting; 1 good quality and 3 poor quality DNA samples from Core were subjected to different conditions in an effort to rescue sequence-ability; conditions: more stringent library cleanup, 30 multiplex PCR cycles, size-selection of template DNA, and 2x input DNA",190225_M03829_0195_000000000-C93PJ,190225_M03829_0195_000000000-C93PJ_version3
CG001Qv40Run75,2019-03-07,"JMctDNA samples of 10 paired patients (Batch 4); FFPE,Frozen tissue and matched DNA from buffy coat (normal)",190307_M03829_0200_000000000-C93TF,190307_M03829_0200_000000000-C93TF_version2
CG001Qv40Run76,,NEVER RUN,,
CG001Qv40Run77,2019-02-28,"Sonic troubleshooting; continuation of CG001Qv40Run74; same 4 samples as Run74 with added conditions: 30 cycles of multiplex PCR in combination with more stringent library cleanup, and more stringent cleanup of multiplex PCR",190228_M02558_0282_000000000-C8TW5,190228_M02558_0282_000000000-C8TW5_version3
CG001Qv40Run78,2019-03-01,Sonic troubleshooting; FFPE samples from Core including same 4 samples as CG001Qv40Run74 with added condition: 28 cycles of multiplex PCR,190301_M02558_0283_000000000-C93T8,190301_M02558_0283_000000000-C93T8_version3
CG001Qv40Run79,2019-02-28,Sonic troubleshooting; same FFPE samples from Core as CG001Qv40Run78 with added condition: 30 cycles of multiplex PCR,190228_M03829_0196_000000000-C94FJ,190228_M03829_0196_000000000-C94FJ_version4
CG001Qv40Run80,2019-03-04,Failed clustering. Aborted. Rerun of Run-78 after 0.9x bead cleanup of 20nM library pool.,,
CG001Qv40Run80(CG001Qv40Run80 rerun),2019-03-05,Rerun of Run-80,190305_M02558_0285_000000000-C94H6,190305_M02558_0285_000000000-C94H6_version3
CG001Qv40Run81,2019-03-14,Group of 10 JMctDNA samples with pre-op and post-op plasma matched (Batch 4),190314_M02558_0288_000000000-C93R8,190314_M02558_0288_000000000-C93R8_version2
CG001Qv40Run82,2019-03-14,"Group of 5 JMctDNA samples with frozen tissue and buffy coat matched (Batch 5), rerun 1 JMctDNA frozen tissue DNA sample (Batch 2) failed in Run70, Group of 5 GyneBank samples with FFPE and buffy coat matched",190314_M03829_0201_000000000-BYBV4,190314_M03829_0201_000000000-BYBV4_version3
CG001Qv40Run83,2019-03-28,"Group of 3 JMctDNA samples with pre-op and post-op plasma matched (Batch 5), 14 follow up post-op plasma matched with previous batches (Batch 6), rerun DNA-13203 that was failed in Run73",190328_M03829_0205_000000000-CC373,190328_M03829_0205_000000000-CC373_version3
CG001Qv40Run84,2019-03-15,Sonic troubleshooting; continuation of CG001Qv40Run74 and CG001Qv40Run77; new conditions examined: 1. 30 cycles of multiplex PCR in combination with 1.4x library cleanup and 2. 30 cycles of multiplex PCR in combination with 1.2x cleanup of multiplex PCR,190315_M02558_0289_000000000-BWRN3,190315_M02558_0289_000000000-BWRN3_version3
CG001Qv40Run85,2019-03-27,15 Manitoba plasma; 5 Gynebank plasma matched with CG001Qv40Run82; Kapa Hifi lot-to-lot validation,190327_M03829_0204_000000000-BWRNR,190327_M03829_0204_000000000-BWRNR_version2
CG001Qv40Run86,2019-04-09,"13 JMctDNA post-op plasma samples (Batch 6), 6 Manitoba plasma samples, QMRS twofold dilution to TruQ0, Seraseq ctDNA 1%AF",190409_M03829_0206_000000000-CBYHM,190409_M03829_0206_000000000-CBYHM_version3
CG001Qv40Run87,2019-03-19,Sonic troubleshooting: 0.9x beads stringent clean up of CG001Qv40Run73 LibCon; Group of 10 JMctDNA samples with pre-op and post-op plasma matched (Batch 3),190319_M03829_0202_000000000-CBYJ9,190319_M03829_0202_000000000-CBYJ9_version3
CG001Qv40Run88,2019-05-02,Comparision of FFPE extraction protocol and UNG treatment-maxwell vs generead DNA extractions,190502_M03829_0210_000000000-CBV92,190502_M03829_0210_000000000-CBV92_version5
CG001Qv40Run89 (6-mers),2019-03-27,10-mer versus 6-mer; only pool A is changed; repeat of Run 64; Run 64 is likely only 24 cycles of multiplex PCR,190327_M02558_0292_000000000-BYCMV_6mers,190327_M02558_0292_000000000-BYCMV_6mers
CG001Qv40Run89 (10-mers),2019-03-27,10-mer versus 6-mer; only pool A is changed; repeat of Run 64; Run 64 is likely only 24 cycles of multiplex PCR,190327_M02558_0292_000000000-BYCMV_10mers,190327_M02558_0292_000000000-BYCMV_10mers
CG001Qv40Run90,2019-03-25,Sonic troubleshooting; rerun of CG001Qv40Run78 after 0.9x bead individual LibCon cleanup instead of 1.8x standard SOP,190325_M02558_0291_000000000-CBYKH,190325_M02558_0291_000000000-CBYKH_version3
CG001Qv40Run91,2019-04-15,19 Manitoba cfdna samples extracted from venous plasma;2 manitoba cfdna samples extracted from arterial plasma,190415_M03829_0207_000000000-CBYJH,190415_M03829_0207_000000000-CBYJH_version3
CG001Qv40Run92,2019-04-17,"Group of 10 GyneBank samples with FFPE and buffy coat matched, Kapa Hifi lot-to-lot validation",190417_M02558_0295_000000000-CBYVC,190417_M02558_0295_000000000-CBYVC_version3
CG001Qv40Run93,2019-04-29,Same group of 10 GyneBank samples with FFPE and buffy coat matched as CG001Qv40Run92 and 1 high concentrated GyneBank FFPE DNA; PCR 28 cycles and 0.9x bead individual LibCon cleanup,190429_M03829_0209_000000000-CBT22,190429_M03829_0209_000000000-CBT22_version3
CG001Qv40Run94,2019-05-16,"Sonic vs CG v4 primers troubleshooting with 3 FFPE DNA; Group of 4 GyneBank samples with FFPE and Buffy coat matched, 2 Manitoba FFPE, QMRS twofold diluted into TruQ0, TruQ0 (PCR 28 cycles and 0.9x bead LibCon cleanup)",190516_M02558_0299_000000000-CF7G5,190516_M02558_0299_000000000-CF7G5_version3
CG001Qv40Run95,2019-05-08,FIND IT v4 validation run 1 with PCR 28 cycles and 0.9x bead LibCon cleanup; 33ng input,190508_M03829_0211_000000000-CBRYT,190508_M03829_0211_000000000-CBRYT_version3
CG001Qv40Run96,2019-05-09,FIND IT v4 validation run 2 with PCR 28 cycles and 0.9x bead LibCon cleanup; inter- & intra-run replicates with Run95; 33ng input,190509_M02558_0298_000000000-CFBMH,190509_M02558_0298_000000000-CFBMH_version3
CG001Qv40Run97,2019-05-23,"3 CAP CFDNA samples, 16 JMctDNA post-op plasma samples (Batch 7 and 8), QMRS and Qiagen Multiplex lot-to-lot validation",190523_M02558_0300_000000000-CF9L5,190523_M02558_0300_000000000-CF9L5_version3
CG001Qv40Run98,2019-05-21,Rerun of Run-93 using expired v3 cartridge. Restricted run lengths to 2x 151bp reads. Expect 30-50% more reads compared to v2 cartridge.,190521_M03829_0213_000000000-B2B6J,190521_M03829_0213_000000000-B2B6J_version3
CG001Qv40Run99,2019-05-29,Group of 2 CEAP Plasma and Buffy coat matched from 1 patient (extracted with Qiagen and Maxwell methods for comparison); 17 JMctDNA post-op plasma samples (Batch 8),190529_M02558_0301_000000000-CF7F3,190529_M02558_0301_000000000-CF7F3_version3
CG001Qv40Run100,2019-06-06,FIND IT v4 validation run 1 redo with PCR 28 cycles and 0.9x bead LibCon cleanup; continuation of CG001Qv40Run95,190606_M03829_0217_000000000-CFBVL,190606_M03829_0217_000000000-CFBVL_version3
CG001Qv40Run101,2019-06-11,FIND IT v4 validation run 2 redo with PCR 28 cycles and 0.9x bead LibCon cleanup; continuation of CG001Qv40Run96,190611_M02558_0303_000000000-CDWWG,190611_M02558_0303_000000000-CDWWG_version3
CG001Qv40Run102,2019-06-17,"FIND IT v4 LOD DNA mixtures, pairs 1, 2, 3 - CG02711 (DNA-11186) in CG02640 (DNA-10414), CG02641 (DNA-10415) in CG02685 (DNA-10637), CG02697 (DNA-11179) in CG02638 (DNA-10412)",190617_M02558_0305_000000000-CFCJ8,190617_M02558_0305_000000000-CFCJ8_version3
CG001Qv40Run103,2019-06-17,"FIND IT v4 LOD DNA mixtures, pairs 4, 5, 6 - CG02890 (DNA-11740) in CG02639 (DNA-10413), CG02739 (DNA-11200) in CG03103 (DNA-12860), CG02695 (DNA-11177) in CG02558 (DNA-9861)",190617_M03829_0220_000000000-CFBNY,190617_M03829_0220_000000000-CFBNY_version3
CG001Qv40Run104,2019-06-12,CEAP plasma (Qiagen vs Maxwell) and buffy coat matched from 1 patient; 18 JMctDNA post-op plasma samples (Batch 8 and 9),190612_M03829_0218_000000000-CFC22,190612_M03829_0218_000000000-CFC22_version2
CG001Qv40Run105,2019-06-13,3 CAP MTP-A 2019 samples; 13 Ukraine ASK FFPE samples; 2 JMctDNA repeat frozen tissue; 2 Seraseq CNV; lot-to-lot validation of the new batch of v4 FIND IT primer pool using QMRS in this run.,190613_M02558_0304_000000000-CF2G5,190613_M02558_0304_000000000-CF2G5_version2
CG001Qv40Run106,2019-06-18,Linear PCR using v4.0 primers; DNA-10035 and NF under different S.O.P. conditions; Pools A-C forward primers are pooled; Pools A-C reverse primers are pooled,190618_M03829_0221_000000000-CF548,
CG001Qv40Run107,2019-07-24,"Group of 5 McGuire FFPE, plasma, and buffy coat matched; 3 Ukraine ASK Health FFPE; Lot-to-lot validation of the new batch of FIND IT v4 primer pool using Blank, QMRS, and NF",190724_M02558_0314_000000000-CJ228,190724_M02558_0314_000000000-CJ228_version2
CG001Qv40Run108,2019-06-27,Qiagen vs Maxwell extraction comparison of 4 Innovative Research normal human plasma and 6 Ukraine ASK Health plasma,190627_M02558_0306_000000000-CF7JJ,190627_M02558_0306_000000000-CF7JJ_version4
CG001Qv40Run109,2019-07-30,"19 JMctDNA pre-op and post-op plasma samples (Batch 9 and 10), 1 JMctDNA FFPE tumour (Batch 10), 1 JMctDNA buffy coat (Batch 10)",190730_M02558_0315_000000000-CJ236,190730_M02558_0315_000000000-CJ236_version2
CG001Qv40Run110,2019-07-04,"FIND IT v4 LOD DNA mixtures, pairs 7, 8, 3 (repeat) - CG03022 (DNA-12469) in CG02655 (DNA-10429), CG02753 (DNA-11353) in CG02684 (DNA-10635), CG02697 (DNA-11179) in CG02638 (DNA-10412)",190704_M03829_0223_000000000-CJ229,190704_M03829_0223_000000000-CJ229_version3
CG001Qv40Run111,2019-07-11,"FIND IT v4 LOD DNA mixtures, pairs 9, 5 (repeat), 10 - CG02698 (DNA-11182) in CG02648 (DNA-10422), CG02739 (DNA-11200) in CG03103 (DNA-12860), CG02591 (DNA-10052) in CG02719 (DNA-11195)",190711_M02558_0308_000000000-CJ23P,190711_M02558_0308_000000000-CJ23P_version5
CG001Qv40Run112,2019-07-15,"FIND IT v4 LOD DNA mixtures, pairs 11, 12, 13 - CG02699 (DNA-11181) in CG02723 (DNA-11197), CG02639 (DNA-10413) in CG02650 (DNA-10424), CG02734 (DNA-11231) in CG02719 (DNA-11195),",190715_M02558_0310_000000000-CJ3BB,190715_M02558_0310_000000000-CJ3BB_version2
CG001Qv40Run112-redo2,2019-07-25,"FIND IT v4 LOD DNA mixtures, pairs 11, 12, 13 - CG02699 (DNA-11181) in CG02723 (DNA-11197), CG02639 (DNA-10413) in CG02650 (DNA-10424), CG02734 (DNA-11231) in CG02719 (DNA-11195),",190725_M03829_0230_000000000-CJ6M8,190725_M03829_0230_000000000-CJ6M8_version3
CG001Qv40Run113,2019-07-08,"FIND IT v4 LOD DNA mixtures - pairs 14, 15, 16 - CG02754 (DNA-11354) in CG03103 (DNA-12860), CG02836 (DNA-11444) in CG02685 (DNA-10637), CG02688 (DNA-10643) in CG02643 (DNA-10417)",190708_M03829_0224_000000000-CF7DW,190708_M03829_0224_000000000-CF7DW_version13
CG001Qv40Run114,2019-07-15,FOLLOW IT validation run 1 with PCR 28 cycles and 0.9X bead LibCon cleanup,190715_M03829_0226_000000000-CJ3BH,190715_M03829_0226_000000000-CJ3BH_version5
CG001Qv40Run115,2019-07-12,FOLLOW IT validation run 2 with PCR 28 cycles and 0.9X bead LibCon cleanup,190712_M02558_0309_000000000-CJ239,190712_M02558_0309_000000000-CJ239_version5
CG001Qv40Run116,2019-07-22,Rerun of CG001Qv40Run114 FOLLOW IT validation run 1 with PCR 28 cycles and 0.9X bead LibCon cleanup,190722_M02558_0313_000000000-CJ3DJ,190722_M02558_0313_000000000-CJ3DJ_version6
CG001Qv40Run117,2019-07-23,Rerun of CG001Qv40Run115 FOLLOW IT validation run 2 with PCR 28 cycles and 0.9X bead LibCon cleanup,190723_M03829_0229_000000000-CHYMH,190723_M03829_0229_000000000-CHYMH_version5
CG001Qv40Run118,2019-07-30,7 Ukraine ASK Health FFPE; Group of 3 GyneBank FFPE and Buffy Coat matched; Lot-to-lot validation of new batch of FIND IT v4 primer pool and Sonic primer troubleshooting,190730_M03829_0231_000000000-CJ6T4,190730_M03829_0231_000000000-CJ6T4_version2
CG001Qv40Run119,2019-08-01,FOLLOW IT: Exactis cfDNA samples from 3 different patients with different time points. PCR cycles:28; LibCon clean-up: 0.9X; Library loaded at 11.5pM.cfDNA was extracted from approximately 2.5ml plasma using the Maxwell protocol.,190801_M02558_0316_000000000-CJ3DF,190801_M02558_0316_000000000-CJ3DF_version2
CG001Qv40Run120,2019-08-20,FOLLOW IT: Exactis cfDNA samples,190820_M03829_0237_000000000-CKJ8D,190820_M03829_0237_000000000-CKJ8D_version2
CG001Qv40Run121,2019-08-06,2 Normal human plasma from PlasmaLab (Qiagen vs Maxwell comparison); 19 Exactis plasma samples with different time points from 7 patients,190806_M03829_0233_000000000-CJ3B6,190806_M03829_0233_000000000-CJ3B6_version2
CG001Qv40Run122,2019-08-20,FOLLOW IT: Exactis cfDNA samples,190820_M02558_0319_000000000-CKK3Y,190820_M02558_0319_000000000-CKK3Y_version2
CG001Qv40Run123,2019-08-30,Group of 1 Sonic Plasma and Buffy Coat matched; 18 Exactis plasma samples from 6 patients; Adapter Set A 20370912 lot-to-lot validation,190830_M02558_0320_000000000-CKJ8T,190830_M02558_0320_000000000-CKJ8T_version3
CG001Qv40Run124,2019-09-03,20 Exactis plasma samples from 7 patients; Adapter Set D 20373636 lot-to-lot validation,190903_M02558_0321_000000000-CKJVY,190903_M02558_0321_000000000-CKJVY_version2
CG001Qv40Run125,2019-09-05,FOLLOW IT validation run 1 ; Exactis cfDNA samples,190905_M02558_0322_000000000-CKM2N,190905_M02558_0322_000000000-CKM2N_version6
CG001Qv40Run126,2019-09-05,FOLLOW IT: Exactis cfDNA samples,190905_M03829_0242_000000000-CKM25,190905_M03829_0242_000000000-CKM25_version2
CG001Qv40Run127,2019-09-10,"FOLLOW IT: 11 Exactis cfDNA, 1 Anna McGuire cfDNA, 6 Sonic (3 cfDNA, 3 buffy coat), 3 Gynebank cfDNA",190910_M03829_0244_000000000-CKJVP,190910_M03829_0244_000000000-CKJVP_version3
CG001Qv40Run128,2019-09-10,"FIND IT v4 LOD mixtures, rerun - CG02641 (DNA-10415) in CG02685 (DNA-10637), CG02695 (DNA-11177) in CG02558 (DNA-9861), CG02591 (DNA-10052) in CG02719 (DNA-11195)",190910_M02558_0324_000000000-CKJV2,190910_M02558_0324_000000000-CKJV2_version3
CG001Qv40Run129,2019-09-20,"Sigma primers (4 blanks, NF, QMRS, 4 FFPE) vs. standard IDT primers (blank, NF, QMRS, same 4 FFPE); 2 Sonic samples (BC, plasma); 2 Seraseq plasma (AF 1% and AF 0.5 %); 1 lot-to-lot validation for Qiagen Mulitplex Mastermix; 2 lot-to-lot validations for two lots of KAPA). Note: Sigma primers contain ESR1 contamination",190920_M02558_0327_000000000-CLTBT,190920_M02558_0327_000000000-CLTBT_version6
CG001Qv40Run130,2019-09-27,FOLLOW IT: Test of IDT unique indexes using CG001Qv40Run114 PCR products (FOLLOW IT validation run 1 with PCR 28 cycles and 0.9X bead LibCon cleanup),190927_M03829_0250_000000000-CMBF8,190927_M03829_0250_000000000-CMBF8_version4
CG001Qv40Run131,2019-09-30,"1 CEAP plasma; 3 McGuire Post-op 3 month plasma; Group of 1 GyneBank FFPE, plasma, and Buffy Coat matched; 14 GyneBank plasma",190930_M03829_0251_000000000-CLTB6,190930_M03829_0251_000000000-CLTB6_version7
CG001Qv40Run132,2019-10-10,"FOLLOW IT: Test of IDT unique indexes; libraries created using PCR products from CG001Qv40Run114/116, CG001Qv40Run115/117, and CG001Qv40Run118, with 10 ul and 5 ul of IDT Indexes",191010_M03829_0254_000000000-CLTFP,191010_M03829_0254_000000000-CLTFP_version6
CG001Qv40Run133,2019-10-15,"RUN FAILED. MiSeq stalled at cycle 107. 12 McGuire samples - 4 patient sample sets (plasma, buffy coat, FFPE); 4 Sonic samples - 2 patient sample sets (2 plasma, 2 buffy coat); 3 CAP CFDNA-B series; 2 EGFR positive FFPE samples for digital PCR",,
CG001Qv40Run134,2019-10-16,"1 CEAP plasma; Group of 2 McGuire samples with FFPE, plasma, and buffy coat matched; 6 FFPE with EGFR variants; Group of 2 GyneBank samples with FFPE, plasma, and buffy coat matched; Resequenced DNA-11754 and DNA-11436 for Madeline",191016_M02558_0331_000000000-CMC45,191016_M02558_0331_000000000-CMC45_version6
CG001Qv40Run135,2019-10-18,"1 CEAP plasma; 15 GyneBank samples - 5 patient sample sets (plasma, buffy coat, FFPE); 3 McGuire samples - 1 patient sample set (plasma, buffy coat, FFPE); 2 Sonic samples - 1 patient sample set (plasma, buffy coat)",191018_M02558_0332_000000000-CMC4K,191018_M02558_0332_000000000-CMC4K_version7
CG001Qv40Run136,2019-10-18,"Repeat of CG001Qv40Run133: 12 McGuire samples - 4 patient sample sets (plasma, buffy coat, FFPE); 4 Sonic samples - 2 patient sample sets (2 plasma, 2 buffy coat); 3 CAP CFDNA-B series; 2 EGFR positive FFPE samples for digital PCR ",191018_M03829_0256_000000000-CMC4C,191018_M03829_0256_000000000-CMC4C_version7
CG001Qv40Run137,2019-10-24,"Plasma LOD Run 1: Horizon cfDNA series DNA mass titration, Hge 20000 to 5000, 2/1/0.75/0.5/0.25/0.1 % VAFs; test LIMS sample sheet on Wallace",191024_M02558_0334_000000000-CM9MH,191024_M02558_0334_000000000-CM9MH_version6
CG001Qv40Run138,2019-10-24,"Plasma LOD Run 2: Horizon cfDNA series DNA mass titration, Hge 2500 to 312.5, 2/1/0.75/0.5/0.25/0.1 % VAFs; test LIMS sample sheet on Gromit",191024_M03829_0259_000000000-CLVRT,191024_M03829_0259_000000000-CLVRT_version8
CG001Qv40Run139,2019-10-22,"1 CEAP plasma; 18 GyneBank samples - 6 patient sample sets (plasma, buffy coat, FFPE); 2 Sonic samples - 1 patient sample set (plasma, buffy coat)",191022_M02558_0333_000000000-CMBFB,191022_M02558_0333_000000000-CMBFB_version7
CG001Qv40Run140,2019-11-08,"FOLLOW IT: Test of IDT unique indexes; libraries created using PCR products from CG001Qv40Run114/116, CG001Qv40Run115/117, CG001Qv40Run118, and CG001Qv40Run129 with 10 ul and 5 ul of IDT Indexes; testing 50 ul LibCon reaction vs. 25 ul LibCon reaction. Incorrect SampleSheet was fixed manually, see: 191108_M02558_0337_000000000-CN68C_1/README",191108_M02558_0337_000000000-CN68C_1,191108_M02558_0337_000000000-CN68C_1_version2
CG001Qv40Run141,2019-11-04,"Plasma LOD Run 3: Seraseq cfDNA series DNA mass titration, HGE 20000 to 5000, 2 / 1 / 0.75 / 0.5 / 0.25 / 0.1 % VAFs (NF contaminated)",191104_M03829_0264_000000000-CN82P,191104_M03829_0264_000000000-CN82P_version6
CG001Qv40Run142,2019-11-04,"Plasma LOD Run 4: Seraseq cfDNA series DNA mass titration, HGE 2500 to 312.5, 2 / 1 / 0.75 / 0.5 / 0.25 / 0.1 % VAFs",191104_M02558_0335_000000000-CN66N,191104_M02558_0335_000000000-CN66N_version6
CG001Qv40Run143,2019-10-31,3 CEAP plasma; Group of 1 Sonic plasma/BC matched; Group of 5 GyneBank FFPE/plasma/BC matched; DNA-13079 resequenced for Madeline,191031_M03829_0263_000000000-CN776,191031_M03829_0263_000000000-CN776_version3
CG001Qv40Run144,2019-11-07,"8 CEAP plasma (2 novel, 6 repeats for testing extraction elution volume); 4 Sonic samples - 2 patient sample set (plasma, BC); 6 GyneBank samples - 2 patient sample sets (plasma, BC, FFPE); 3 CAP MTP-B proficiency samples",191107_M02558_0336_000000000-CN6CD,191107_M02558_0336_000000000-CN6CD_version3
CG001Qv40Run145,2019-11-21,"(Single tube assay, no codewords, custom sample indexes) IDT rhAmpSeq - 16 samples including 4 Horizon and 4 Seraseq cfDNA controls, Horizon Oncospan, 1 normal and 1 patient plasma, and 2 FFPE samples",191121_M03829_0271_000000000-CN67F,191121_M03829_0271_000000000-CN67F
CG001Qv40Run146,2019-11-20,"2 CEAP plasma; 3 McGuire samples - 1 patient sample set (plasma, BC, FFPE); 12 GyneBank samples - 4 patient sample sets (plasma, BC, FFPE); 4 Sonic samples - 2 patient sample sets (plasma, BC)",191120_M02558_0338_000000000-CN65M,191120_M02558_0338_000000000-CN65M_version3
CG001Qv40Run147,2019-11-27,"Sigma primers (3 blanks, NF, QMRS, 2 FFPE) vs. standard IDT primers (blank, NF, QMRS, same 2 FFPE); standard 3 primer pools (blank, NF, QMRS, 3 FFPE) vs. 2 primer pools (blank, NF, QMRS, same 3 FFPE)",191127_M03829_0272_000000000-CN58M,191127_M03829_0272_000000000-CN58M_version3
CG001Qv40Run148,2019-12-03,"(Single tube assay, no codewords) PanelPlex - 18 reactions using 6 samples (blank, QMRS, NF, FFPE DNA-11186, Horizon 5% cfDNA, Horizon 1% cfDNA) and 4 multiplex primer mixes defined by design quality (good, good+poor, good+poor+fail, CG A+B+C)",191203_M03829_0274_000000000-CN8GJ,
CG001Qv40Run149,2019-11-29,"Repeat of Plasma LOD Run 3: Seraseq cfDNA series DNA mass titration, HGE 20000 (66 ng) to 5000 (16.5 ng), 2 / 1 / 0.75 / 0.5 / 0.25 / 0.125 % VAFs; 0.75% generated from 2% plus WT",191129_M03829_0273_000000000-CN94V,191129_M03829_0273_000000000-CN94V_version2
CG001Qv40Run150,2019-12-04,3 CEAP plasma and 2 CEAP buffy coats; 2 sets of Sonic plasma/BC matched; 2 sets of McGuire FFPE/plasma/BC matched; 2 sets of GyneBank FFPE/plasma/BC matched,191204_M03829_0275_000000000-CN65P,191204_M03829_0275_000000000-CN65P_version3
CG001Qv40Run151,2019-12-09,3 CEAP plasma; Group of 6 GyneBank FFPE/plasma/BC matched,191209_M03829_0277_000000000-CRFPD,191209_M03829_0277_000000000-CRFPD_version2
CG001Qv40Run152,2019-12-10,"Thermo Fisher primers (3 BLANKs, QMRS, NF, 4 FFPE) vs current IDT primers (BLANK, QMRS, NF, same 4 FFPE); FIND IT v4 LOD DNA mixtures using different background - CG02641 (DNA-10415) in CG02890 (DNA-11740) at 3 / 2 / 1.5 / 0.5 % VAFs",191210_M02558_0339_000000000-CT9RN,191210_M02558_0339_000000000-CT9RN_version3
CG001Qv40Run153,2019-12-11,"standard 3 primer pools vs. Pedro's 2 primer pools; Horizon/Seraseq plasma LODs at 8.25 ng/2500 HGE input, Horizon standards, and 4 FFPE",191211_M03829_0278_000000000-CTB6P,191211_M03829_0278_000000000-CTB6P_version3
CG001Qv40Run154,2019-12-18,"FOLLOW IT: Test of IDT unique indexes; libraries created using PCR products from CG001Qv40Run121, CG001Qv40Run137, and CG001Qv40Run142 with 10 ul and 5 ul of IDT Indexes; testing 50 ul LibCon reaction vs. 25 ul LibCon reaction",191218_M02558_0340_000000000-CTBGP,191218_M02558_0340_000000000-CTBGP_version2
CG001Qv40Run155,2019-12-17,3 CEAP plasma; 3 McGuire 3-month post op and 3 sets of McGuire FFPE/plasma/BC matched; 2 sets of Sonic plasma/BC matched; 1 Sheffield FFPE; 1 clinical FFPE from Mexico,191217_M03829_0280_000000000-CTFBY,191217_M03829_0280_000000000-CTFBY_version4
CG001Qv40Run156,2019-12-23,"2 CEAP plasma; 1 McGuire 3-month post-op, 3 sets of Sonic plasma/BC matched and 4 sets of Gynebank FFPE/plasma/BC matched",191223_M03829_0282_000000000-CTFCM,191223_M03829_0282_000000000-CTFCM_version4
CG001Qv40Run157,2019-12-31,"FIND IT validation Run 1; GyneBank FFPE, Ukraine FFPE, Anna McGuire FFPE, and AMSBIO FFPE",191231_M03829_0283_000000000-CT9RM,191231_M03829_0283_000000000-CT9RM_version4
CG001Qv40Run158,2020-01-13,"CG primers 1-pool and 3-pool with 4 min extension, 35 cycles, and NEB 5x multiplex PCR premix",200113_M03829_0287_000000000-CTC9R,200113_M03829_0287_000000000-CTC9R_version2
CG001Qv40Run159,2020-01-03,"FIND IT validation Run 2; Anna McGuire FFPE,Ukraine ASK Health FFPE,Spectrum Health (USA) FFPE,GyneBank FFPE, AMSBIO FFPE, and Reprocell FFPE",200103_M02558_0341_000000000-CTBF5,200103_M02558_0341_000000000-CTBF5_version2
CG001Qv40Run160,2020-01-07,1 CEAP plasma; Group of 6 GyneBank FFPE/plasma/BC matched; Lot to lot validation of Qiagen Multiplex lot 163034980,200107_M03829_0285_000000000-CTFCG,200107_M03829_0285_000000000-CTFCG_version3
CG001Qv40Run161,2020-01-09,"2 CEAP plasma samples (one redo), 6 sets of Gynebank matched plasma, FFPE, BC",200109_M03829_0286_000000000-CTFC4,200109_M03829_0286_000000000-CTFC4_version3
CG001Qv40Run162,2020-01-10,wrong sample names IDT unique indexes test: PCR products from CG001Qv40Run153 with 5uL index mix in 25uL LibCon reaction,"200110_M02558_0343_000000000-CT9RK (wrong sample names, re-queued as Run175)",200110_M02558_0343_000000000-CT9RK_1_version2
CG001Qv40Run163,2020-01-20,1 CEAP plasma; Group of 5 AM FFPE/plasma/BC matched; 3 AM plasmas for extraction testing,200120_M03829_0288_000000000-CTFCB,200120_M03829_0288_000000000-CTFCB_version2
CG001Qv40Run164,2020-01-27,IDT unique indexes test: PCR products from CG001Qv40Run153 with 5uL index mix in 25uL LibCon reaction; testing 2.5 ul of DNA template,200127_M02558_0344_000000000-CTFC9,200127_M02558_0344_000000000-CTFC9_version2
CG001Qv40Run165,2020-02-04,21 JMctDNA post-op plasma samples (Batch 11),200204_M02558_0346_000000000-CW6BJ,200204_M02558_0346_000000000-CW6BJ_version2
CG001Qv40Run166,2020-01-27,"1 CEAP plasma; 5 sets of GyneBank FFPE/plasma/BC; QMRS, Qiagen mulitplex, and Kapa HiFi lot-to-lot validation; Please note sequencing reads may be affected by evaporation during PCR for DNA-17300, DNA-17444, DNA-11806, and DNA-11811",200127_M03829_0290_000000000-CTC88,200127_M03829_0290_000000000-CTC88_version2
CG001Qv40Run167,2020-01-31,2 CEAP plasma samples; 1 set of Sonic plasma/BC; 2 McGuire plasmas; 5 sets of GyneBank FFPE/plasma/BC matched,200131_M03829_0292_000000000-CW6Y3,200131_M03829_0292_000000000-CW6Y3_version2
CG001Qv40Run168,2020-02-06,1 CEAP plasma;6 trios of GyneBank FFPE/Plasma/BC,200206_M03829_0293_000000000-CW99W,200206_M03829_0293_000000000-CW99W_version2
CG001Qv40Run169,2020-02-14,"2 CEAP plasma; 1 normal human plasma from PlasmaLab; Group of 6 GyneBank FFPE, plasma, BC matched",200214_M03829_0294_000000000-CW8WJ,200214_M03829_0294_000000000-CW8WJ_version2
CG001Qv40Run170,2020-03-02,Testing v4 2 pool (Pedro's 2 primer pool) with 4 minute extensions for both 28 and 35 cycles; testing v5 2 pool with 4 minute extension and 28 cycles,200302_M03829_0298_000000000-CWBRW,200302_M03829_0298_000000000-CWBRW_version2
CG001Qv40Run171,2020-02-27,1 CEAP plasma; 3 CAP MTP-A 2020 samples; Group of 5 GyneBank FFPE/plasma/BC matched,200227_M03829_0296_000000000-CW97K,200227_M03829_0296_000000000-CW97K
CG001Qv40Run172,2020-02-28,"ExoI test run with 3 sample template types (FFPE, Normal plasma, buffy coat)-FAILED",,
CG001Qv40Run173,2020-02-28,"ExoI test run with 3 sample template types (FFPE, Normal plasma, buffy coat)",200228_M03829_0297_000000000-CW6BB,200228_M03829_0297_000000000-CW6BB
CG001Qv40Run174,2020-03-04,2 CEAP plasma; 3 sets of Sonic plasma/BC; 4 AM post-op plasmas; 3 sets of GyneBank plasma/FFPE/BC,200304_M03829_0299_000000000-CW7H2,200304_M03829_0299_000000000-CW7H2_version3
CG001Qv40Run175,2020-03-16,OUTPUT PUT IN CG001Qv40Run162. Re-queue of CG001Qv40Run162; IDT unique indexes test: PCR products from CG001Qv40Run153 with 5uL index mix in 25uL LibCon reaction.,200110_M02558_0343_000000000-CT9RK_1 (re-queue of run Run162),
CG001Qv40Run176,2020-03-18,REQUEUED AS CG001Qv40Run178. Contains incorrect mixed sample labels. 1 CEAP plasma; 20 Sonic plasma ctDNA extracted by Sonic,200318_M03829_0302_000000000-CW8HR_original(contains fastq files labelled Run176 and Run178),
CG001Qv40Run177,2020-03-26,"1 CEAP EORLA plasma; 4 JMctDNA plasma; Group of 4 GyneBank FFPE, plasma, BC matched; Lot-to-lot validation for 1 QMRS and 2 lots of Kapa",200326_M03829_0303_000000000-CW69K,200326_M03829_0303_000000000-CW69K
CG001Qv40Run178,2020-04-02,Re-queue of CG001Qv40Run176 (fixed sample IDs); 1 CEAP plasma; 20 Sonic plasma ctDNA extracted by Sonic,200318_M03829_0302_000000000-CW8HR_fixed,200318_M03829_0302_000000000-CW8HR_fixed_version2
CG001Qv40Run179,2020-04-08,failed run: contamination in blank and noisy NF (see FIMP-193) CEAP/EORLA plasma; 7 Sonic plasma for re-sequencing; 5 sets of Sonic plasma and BC matched; 3 post-op McGuire plasma,200408_M03829_0306_000000000-J478J,200408_M03829_0306_000000000-J478J
CG001Qv40Run180,2020-04-15,1 CEAP plasma; 1 CEAP/EORLA plasma (redo); Group of 6 Gynebank plasma/FFPE/BC matched; kappa lot to lot validation,200415_M03829_0308_000000000-J3FWK,200415_M03829_0308_000000000-J3FWK
CG001Qv40Run181,2020-04-22,1 CEAP plasma; Group of 6 GyneBank plasma/FFPE/BC matched,200422_M03829_0311_000000000-J5529,200422_M03829_0311_000000000-J5529
CG001Qv40Run182,2020-04-28,7 OHSU plasma from 3 patients; 6 normal human plasma from Innovative Research and PlasmaLab for resequencing; Group of 2 GyneBank plasma/FFPE/BC matched,200428_M03829_0314_000000000-J56KG,200428_M03829_0314_000000000-J56KG
CG001Qv40Run183,2020-05-06,1 CEAP plasma sample; 1 group of AM plasma/FFPE/BC matched; 1 group of GyneBank plasma/FFPE/BC matched; 1 normal human plasma from PlasmaLab; 5 groups of Sonic plasma/BC matched and 3 AM plasmas for resequencing (oringially sequenced in CG001Qv40Run179),200506_M03829_0316_000000000-J5792,200506_M03829_0316_000000000-J5792
CG001Qv40Run184,2020-05-12,THIS RUN FAILED very early on in the sequencing run and was re-run as CG001Qv40Run187. There should be no data associated with this run; samples 1-12 are a comparison of a bead-based cleanup to an enzymatic (Exo I) cleanup; samples 13-24 is a lot-to-lot validation of new primers from IDT; 1% PhiX,,
CG001Qv40Run185,2020-05-13,"1 CEAP Sample; 6 sets of Gynebank-cfDNA,FFPE DNA,gDNA(buffycoat),2 normal cfDNA samples from normal plasma",200513_M03829_0319_000000000-J554V,200513_M03829_0319_000000000-J554V
CG001Qv40Run186,2020-05-11,"Use CG001Qv40Run140 output. DNA-13244-CG001Qv40Run186-5 was very small after re-queue. Re-queue of CG001Qv40Run140 (fixed sample IDs); FOLLOW IT: Test of IDT unique indexes; libraries created using PCR products from CG001Qv40Run114/116, CG001Qv40Run115/117, CG001Qv40Run118, and CG001Qv40Run129 with 10 ul and 5 ul of IDT Indexes; testing 50 ul LibCon reaction vs. 25 ul LibCon reaction",191108_M02558_0337_000000000-CN68C (fastq files from re-queue of run CG001QV40Run140 in Alignment_Imported_1/20200511_143451/Fastq/),191108_M02558_0337_000000000-CN68C_1_version2
CG001Qv40Run187,2020-05-12,Re-do of CG001Qv40Run184 which failed early on in the sequencing run; samples 1-12 are a comparison of a bead-based cleanup to an enzymatic (Exo I) cleanup; samples 13-24 is a lot-to-lot validation of new primers from IDT; 1% PhiX,200512_M02558_0365_000000000-J579G,200512_M02558_0365_000000000-J579G
CG001Qv40Run188,2020-06-09,"7 CEAP samples, 4 sets of Gynebank-cfDNA,FFPE DNA, gDNA(buffy coat), 2 cfDNA samples from normal plasma",200609_M03829_0328_000000000-J65G9,200609_M03829_0328_000000000-J65G9
CG001Qv40Run189,2020-06-12,Testing UDIs; PCR products from CG001Qv40Run174,200612_M02558_0373_000000000-J65GH,
CG001Qv40Run190,2020-06-12,Testing UDIs; PCR products from CG001Qv40Run180,200612_M03829_0329_000000000-J5W6W,
CG001Qv40Run191,2020-06-17,"1 CEAP, 6 sets of GyneBank plasma/FFPE/BC, 2 normal plasma",200617_M02558_0374_000000000-J64YG,200617_M02558_0374_000000000-J64YG
CG001Qv40Run192,2020-06-29,"Validation of Eppendorf thermalcycler Run 1; 2 FFPE, 1 buffy coat, 2 normal plasmas",200629_M03829_0333_000000000-J656Y,200629_M03829_0333_000000000-J656Y
CG001Qv40Run193,2020-06-24,"High tile error rate. Repeated as CG001Qv40Run194. 2 CEAP plasma; 1 Kapa lot-to-lot validation (lot no 000105448), 1 NF lot- to-lot validation(D2_143527); 12 CEAP plasma with 2x resin protocol; 1 Normal plasma with std extraction protocol; 1 Normal plasma with 2X resin protocolH",200624_M02558_0377_000000000-J65YJ,200624_M02558_0377_000000000-J65YJ
CG001Qv40Run194,2020-07-08,"Re-do of CG001Qv40Run193; 2 CEAP plasma; 1 Kapa lot-to-lot validation (lot no 000105448), 1 NF lot- to-lot validation(D2_143527); 12 CEAP plasma with 2x resin protocol; 1 Normal plasma with std extraction protocol; 1 Normal plasma with 2X resin protocol",200708_M03829_0334_000000000-J6PLM,200708_M03829_0334_000000000-J6PLM
CG001Qv40Run195,2020-07-09,Group of 3 ACTT plasma matched (locked down extraction method for reporting and 2X resin extraction test with proteinase K treatment); Group of 4 McGurie FFPE/plasma/BC matched; 3 McGuire FFPE,200709_M03829_0335_000000000-J6PM2,
CG001Qv40Run196,2020-07-16,"RUN FAILED; 3 ACTT plasmas, 1 AM FFPE, 5 sets of mathced GyneBank FFPE/BC/plasma, lot to lot validaitons for NF and KAPA HiFi",,
CG001Qv40Run197,2020-07-17,"Re-load of CG001Qv40Run196; 3 ACTT plasmas, 1 AM FFPE, 5 sets of mathced GyneBank FFPE/BC/plasma, lot to lot validaitons for NF and KAPA HiFi",200717_M03829_0337_000000000-J6WB9,200717_M03829_0337_000000000-J6WB9
CG001Qv40Run198,2020-07-24,"UDI orientation (8X3) Testing Run 1 for v4 efficiency release; 8 FFPE, 2 BC, 7 Horizon cfDNA mixtures AF 5, 2, 1, 0.75, 0.5, 0.25, 0%, 4 normal human plasma extracted using locked down SOP, 2x resin, and Proteinase K with 2x resin methods",200724_M02558_0382_000000000-J6WC6,200724_M02558_0382_000000000-J6WC6
CG001Qv40Run199,2020-07-29,"UDI orientation (8X3) Testing Run 2 for v4 efficiency release; 8 FFPE, 2 BC, 7 Horizon cfDNA mixtures AF 5, 2, 1, 0.75, 0.5, 0.25, 0%, 4 normal human plasma extracted using locked down SOP, 2x resin, and Proteinase K with 2x resin methods",200729_M03829_0340_000000000-J6PLW,200729_M03829_0340_000000000-J6PLW
CG001Qv40Run200,2020-07-22,"7 ACTT plasma, 4 sets of GyneBank FFPE/BC/plasma, 2 Normal plasma",200722_M03829_0338_000000000-J6PLN,
CG001Qv40Run201,2020-07-28,5 ACTT plasma (1 from EORLA); Group of 5 GyneBank FFPE/BC/plasma matched; 1 normal human plasma from Innovative Research,200728_M02558_0383_000000000-J6WF4,
CG001Qv40Run202,2020-07-31,"4 ACTT plasma, 5 sets of GyneBank FFPE/BC/plasma",200731_M03829_0341_000000000-J6W9V,
CG001Qv40Run203,2020-08-05,19 ACTT plasma (1 from EORLA),200805_M03829_0343_000000000-J6WDK,
CG001Qv40Run204,2020-08-12,Failure of primer pool C. 20 ACTT plasma (3 from EORLA); resequence DNA-20178 to confirm result in Run203,200812_M02558_0387_000000000-J6WDC,
CG001Qv40Run205,2020-08-20,"v4 efficiency validation #1 using BioRad: Ukraine FFPE, GyneBank FFPE, McGuire FFPE, and CEAP plasma",200820_M03829_0350_000000000-J6RHV,
CG001Qv40Run206,2020-08-13,"v4 efficiency validation #2: Ukraine, GyneBank, AM, and CEAP",200813_M03829_0347_000000000-J7K83,
CG001Qv40Run207,2020-08-18,"v4 efficiency validation #3: Ukraine, GyneBank, AM, Amsbio, and CEAP",200818_M02558_0389_000000000-J6W97,
CG001Qv40Run208,2020-08-17,Redo of CG001Qv40Run204; 20 ACTT plasma (3 from EORLA); resequence DNA-20481 to confirm result in Run203,200817_M03829_0348_000000000-J6WCH,
CG001Qv40Run209,2020-08-18,"18 ACTT plasma, 1 set of GyneBank FFPE/BC/plasma",200818_M03829_0349_000000000-J6PKC,
CG001Qv40Run210,2020-08-24,"18 ACTT Plasma, 3 CAP CFDNA-A 2020 plasma",200824_M02558_0391_000000000-JB8JD,
CG001Qv40Run211,2020-08-29,21 ACTT plasma,200828_M03829_0353_000000000-JB7C2,
CG001Qv40Run212,2020-09-01,"5 ACTT plasma repeats, 13 ACTT plasma first time, 3 CAP MTP (4,5,6)",200901_M03829_0354_000000000-JB87R,
CG001Qv40Run213,2020-09-04,"20 ACTT Plasma, 1 A.McGuire FFPE",200904_M02558_0394_000000000-J8YBL,
CG001Qv40Run214,2020-09-09,1 EORLA FFPE and 20 ACTT plasma (4 from EORLA and 1 from Genolife),200909_M03829_0356_000000000-JB7BW,
CG001Qv40Run215,2020-09-11,"1 ACTT Plasma repeat, 19 ACTT Plasma,1 Lab Genomics",200911_M02558_0396_000000000-JB737,
CG001Qv42Run216,2020-09-16,16 ACTT plasma; 1 Lab Genomics plasma; 1 ACTT plasma repeat from CG001Qv40Run215 PCR product; 1 Lab Genomics plasma repeat; 1 McGuire FFPE; Lot-to-lot validation for Qiagen Multiplex 163052861,200916_M03829_0357_000000000-JB7CG,
CG001Qv42Run217,2020-09-18,"19 ACTT Plasma, 1 ACTT Plasma Repeat, 1 AMcGuire FFPE",200918_M03829_0358_000000000-JB7CV,
CG001Qv42Run218,2020-09-23,"2 ACTT plasma repeats, 19 ACTT plasma samples",200923_M02558_0400_000000000-JB72D,
CG001Qv42Run219,2020-09-25,"1 ACTT plasma repeat, 10 ACTT plasma samples, 11 Find It R&D samples for Tony Ng",200925_M02558_0401_000000000-JB8B3,
CG001Qv42Run220,2020-09-30,1 Lab Genomics plasma; 19 ACTT plasma; 1 ACTT plasma repeat,200930_M03829_0361_000000000-JB8JY,
CG001Qv42Run221,2020-10-02,21 ACTT plasma,201002_M03829_0362_000000000-JB8BW,
CG001Qv42Run222,2020-10-06,"13 ACTT Plasma, 4 A.McGuire Plasma, 4 A.McGuire FFPE",201006_M02558_0406_000000000-JB7CF,
CG001Qv42Run223,2020-10-09,21 ACTT Plasma,201009_M03829_0365_000000000-JBV6T ,
CG001Qv42Run224,2020-10-14,19 ACTT plasma; 1 group of GyneBank FFPE and BC matched,201014_M03829_0366_000000000-JBV6Y,
CG001Qv42Run225,2020-10-19,21 ACTT plasma,201019_M02558_0410_000000000-JBV74,
CG001Qv42Run226,2020-10-21,20 ACTT plasma. 1 Exactic SMX plasma.,201021_M02558_0411_000000000-JBV7F,
CG001Qv42Run227,2020-10-23,21 ACTT plasma,201023_M03829_0370_000000000-JC7BY,
CG001Qv42Run228,2020-10-27,20 ACTT plasma; QMRS lot-to-lot validation,201027_M03829_0371_000000000-JC7D3,201027_M03829_0371_000000000-JC7D3
CG001Qv42Run229,2020-10-28,v4 F-It (samples 1-12) and v2 Fusions (Samples 13-24) blended run. A blended run consisting of followit and fusion assay libraries needs to be sequenced to determine whether this can be done by partners. All samples using the IDT for Illumina 10nt index adapters. Run controls and samples for both assays. Samples 1-3: followIt controls. Samples 4-12: followit samples. Samples 13-15: fusion controls. Samples 16-24: fusion samples,201028_M03829_0372_000000000-JBV6D,
CG001Qv42Run230,2020-10-30,20 ACTT plasmas (2 repeats) and 1 Exactis SMX plasma,201030_M03829_0373_000000000-JBTN6,
CG001Qv42Run231,2020-11-03,20 ACTT plasmas; QMRS lot-to-lot validation,201103_M03829_0374_000000000-JC7CJ,
CG001Qv42Run232,2020-11-06,21 ACTT plasmas,201106_M02558_0415_000000000-JBTYJ,
CG001Qv42Run233,2020-11-06,"14 ACTT plasmas, 2 sets of AM plasma/BC/FFPE, 1 AM FFPE stand-alone,",201106_M03829_0376_000000000-JBTYP,
CG001Qv42Run234,2020-11-10,"1 ACTT plasma repeat, 1 Protean BioDiagnostics plasma, 1 Exactis SMX plasma, 18 ACTT plasma",201110_M03829_0377_000000000-JC2CC,
CG001Qv42Run235,2020-11-13,"14 ACTT plasma, 7 Anna McGuire plasma samples (3 of them with new Proteinase K treatment)",201113_M02558_0416_000000000-JC7JL,
CG001Qv42Run236,2020-11-16,"16 ACTT Plasma, 5 GyenBank FFPE",201116_M03829_0378_000000000-JC7CW,
CG001Qv42Run237,2020-11-18,"2 ACTT plasma repeat, 18 ACTT plasma, 1 Exactis SMX plasma",201118_M03829_0379_000000000-JDJ78,
CG001Qv42Run238,2020-11-20,"2 ACTT plasma repeat,14 ACTT plasma, 1 Exactis SMX, 4 GyneBank samples",201120_M03829_0380_000000000-JDJRW,
CG001Qv42Run239,2020-11-24,3 ACTT plasma repeat; 18 ACTT plasma,201124_M02558_0419_000000000-JDJ76,
CG001Qv42Run240,2020-11-27,"15 ACTT plasma repeats; 6 Anna McGuire samples (2 patients, each with buffy coat, plasma, and FFPE)",201127_M03829_0382_000000000-JDJM9,
CG001Qv42Run241,2020-11-30,19 ACTT plasma; lot-to-lot validation for 2 lots of Qiagen Multiplex Mastermix (lot 163052861 and 166026182),201130_M02558_0420_000000000-JDJHH,
CG001Qv42Run242,2020-12-01,21 ACTT plasma,201201_M03829_0383_000000000-JDM29,
CG001Qv42Run243,2020-12-03,Exactis R&D plasma,201203_M03829_0384_000000000-JDJ77,
CG001Qv42Run244,2020-12-02,RUN FAILED: 21 ACTT plasma,201202_M02558_0421_000000000-JDM3P,
CG001Qv42Run245,2020-12-05,21 ACTT repeat plasma samples,201205_M03829_0385_000000000-JDJ65,
CG001Qv42Run246,2020-12-07,2 ACTT plasma repeat; 17 ACTT plasma; 1 GyneBank plasma; 1 VGH GIST FFPE repeat,201207_M02558_0422_000000000-JDJ7B,
CG001Qv42Run247,2020-12-09,Exactis R&D plasma,201209_M02558_0423_000000000-JDM47,
CG001Qv42Run248,2020-12-09,18 ACTT plasma and 3 Exactis Plasma,201209_M03829_0386_000000000-JDJN7,
